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Increased expression of the chondroitin proteoglycan NG2 is a prominent feature in central nervous system injury with unknown
cellular source and biological relevance. Here, we describe the first detailed analysis of experimental autoimmune encephalo-
myelitis in NG2 knockout mice and NG2 knockout bone marrow chimeras. We show that both macrophages and oligodendro-
cyte progenitor cells express and secrete NG2 in response to transforming growth factor-b. A subpopulation of macrophages
expresses NG2 within leucocyte infiltrates in the central nervous system, but only oligodendrocyte progenitor cells contribute to
NG2 accumulation. Notably, NG2 plays no role in experimental autoimmune encephalomyelitis initiation, progression or recu-
peration. In concurrence, the immune response is unaltered in NG2-deficient mice as are the extent of central nervous system
damage and degree of remyelination.
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Introduction
The glial scar is considered a major obstacle in effective recovery
of the CNS from insult. Virtually all CNS injuries, including the
autoimmune disease multiple sclerosis, trigger rapid activation of
astrocytes, microglia, macrophages and oligodendrocyte progenitor
cells (Fawcett and Asher, 1999; Alonso, 2005), which in turn
deposit chondroitin sulphate proteoglycans (Dou and Levine, 1994;
Tang et al., 2003; Laabs et al., 2007). The high molecular weight
chondroitin sulphate proteoglycan NG2 (CSPG-4) is a prominent
component of the glial scar (Tang et al., 2003; Tan et al., 2005)
and is considered a major obstacle for axon regeneration, remye-
lination and CNS recovery (de Castro et al., 2005; Dou and
Levine, 1994; Fawcett and Asher, 1999; Chen et al., 2002;
Morgenstern et al., 2002; Larsen et al., 2003; Tang et al.,
2003; Tan et al., 2005, 2006; Laabs et al., 2007), although this
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view is now being questioned (Ughrin et al., 2003; de Castro
et al., 2005; Tan et al., 2006; Hossain-Ibrahim et al., 2007).
Although the rapid accumulation of NG2 is a common feature
of damage to the CNS, the biological role of NG2 in CNS injury is
still a conundrum. The short intracellular domain of NG2 binds
various signalling molecules that may link NG2 to synapses and
the cytoskeleton. The large extracellular domain (290 kDa) con-
tains several disulphide bonds, N-glycosylation sites and a single
chondroitin chain, and binds a wide array of proteins including
receptors, growth factors, extracellular matrix components and
proteases, indicating that NG2 may regulate diverse cellular pro-
cesses (Stallcup, 2002; Nishiyama et al., 2009; Trotter et al.,
2010). Importantly, the extracellular domain of NG2 can be
cleaved off and incorporated into the extracellular matrix
(Nishiyama et al., 1995; Asher et al., 2005). The high concentra-
tion of proteases and large numbers of NG2 expressing cells at
sites of inflammation in the CNS may explain the high amount of
NG2 in the glial scar. The biological function of NG2 shedding in
response to CNS injury remains to be addressed.
Surprisingly, the cellular source of NG2 in areas of CNS damage
has become a matter of debate. Although oligodendrocyte
progenitor cells are generally considered responsible for NG2 ac-
cumulation [NG2 is a marker for these cells (Nishiyama et al.,
2009; Trotter et al., 2010)] recent reports indicate that activated
microglia and CNS-infiltrating macrophages may also express NG2
after CNS injury (Bu et al., 2001; Jones et al., 2002; Yokoyama
et al., 2006; Fiedorowicz et al., 2008; Matsumoto et al., 2008;
Smirkin et al., 2009; Zhu et al., 2010). Blood-derived mono-
cytes and macrophages, and microglia play pivotal roles in
CNS injury and can cause extensive CNS damage including
axonopathy and demyelination, events that trigger substantial
oligodendrocyte progenitor cell activation and glial scar formation
(Di Bello et al., 1999; Reynolds et al., 2002; Alonso, 2005; Foote
and Blakemore, 2005; Rhodes et al., 2006; Mildner et al., 2009).
Importantly, NG2 may mediate the inflammatory response of
activated microglia (Gao et al., 2010). However, the signals
triggering NG2 expression in macrophages and microglia are cur-
rently unknown and whether these cells do contribute to NG2
accumulation—and their large numbers at sites of inflammation
and in the glial scar support such a notion—has not yet been
addressed.
In this study, we have investigated the cellular source(s) of
deposited NG2, the signals triggering NG2 expression and its
function in myelin oligodendrocyte glycoprotein-induced experi-
mental autoimmune encephalomyelitis (EAE), the murine model
system for multiple sclerosis. We show that transforming growth
factor-b (TGF-b) upregulates NG2 expression and secretion by
oligodendrocyte progenitor cells and macrophages and demon-
strate that NG2 is redundant in EAE progression, recruitment
of leucocytes into the CNS, neuronal damage, demyelination
and importantly, remyelination. Finally, we prove that blood-
derived macrophages express NG2 in the CNS during EAE but
do not contribute to the accumulation of NG2 at sites of inflam-
mation. Our data excludes a prominent role for NG2 in immune
regulation and regeneration in autoimmune inflammation of
the CNS.
Materials and methods
Mice
Seven- to eight-week-old C57Bl/6 female mice were purchased from
Harlan. NG2 knockout mice were a kind gift from Prof. William B.
Stallcup, Burnham Institute for Medical Research, and backcrossed to
C57Bl/6 background for nine generations.
To generate bone marrow chimeras, mice were lethally irradiated
with a split-dose of 1000 rad. Donor animals were euthanized with
CO2 and bones (fore- and hind legs, hips) were flushed with sterile
phosphate buffered saline to obtain bone marrow stem cells. In total,
5  106 total bone marrow cells were injected intravenously per
mouse. To prevent bacterial infection, 1% Neomycin (Sigma) was
added for 2 weeks to the drinking water. After 6 weeks, prior to
myelin oligodendrocyte glycoprotein immunization, reconstitution
was verified by flow cytometry with anti-CD45.1 and anti-CD45.2
(BD PharMingen) on circulating leucocytes isolated from blood
samples. Average reconstitution exceeded 97%.
All animal experiments were approved by the Swiss Veterinary
Office (115/05; Zurich, Switzerland) and performed according to fed-
eral and institutional guidelines.
Reagents
Cytokines, growth factors and chemicals were obtained from the fol-
lowing sources. Roche Diagnostics: mTNF- and mIFN-. PeproTech:
rmIL-1 b, hIL-2, mIL-6, rmIL-13, rhTGF-b 2 and M-CSF. BD
PharMingen: rmIL-10. Antibodies to NG2 were either a kind gift
from Prof. William B. Stallcup or obtained from Chemicon. Anti-
b-tubulin-horseradish peroxidase and anti-b-actin-horseradish peroxid-
ase were purchased from Abcam and Sigma, respectively. Antibodies
to CD3 (biotin), CD4 (PE), CD8 (FITC), CD11b (biotin), B220 (biotin)
and Gr1 (FITC), were obtained from BD PharMingen and F4/80 (FITC)
from Serotec. CD11b (unlabelled), CD16/32 (Fc block) and CD45
(APC) were purchased from Biolegend and CD11c (clone N418, PE)
from Caltag. The secondary antibody anti-rabbit horseradish peroxid-
ase was obtained from Pierce. Anti-rat Alexa 488 and anti-rabbit
Alexa 594 were purchased from Molecular Probes/Invitrogen and
Streptavidin-APC-Cy7 from Biolegend.
Experimental autoimmune
encephalomyelitis induction
Mice were injected with 100 mg myelin oligodendrocyte glycopro-
tein35-55 (Anawa) in 200 ml phosphate-buffered saline: complete
Freund’s adjuvant (Difco) (1:1) subcutaneously on the right flank
and with 300 ng Pertussis toxin (List Biological Laboratories) intraper-
itoneally (i.p.) on Day 0, followed by a boost of 300 ng Pertussis toxin
at Day 2 and 100mg myelin oligodendrocyte glycoprotein35–55 in com-
plete Freund’s adjuvant into the left flank on Day 7. The scoring of
clinical symptoms was performed as described previously (Moransard
et al., 2010).
Primary cells and cell lines
Primary oligodendrocyte progenitor cells were isolated as described
previously (Moransard et al., 2010). Briefly, neonatal forebrain cells
were harvested from 1- to 2-day-old neonate C57/BL6 mice by
dissociation of cortices in papain (Sigma) and grown in Dulbecco’s
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modified Eagle’s medium (Gibco) supplemented with 10% horse
serum (Gibco) on poly-D-lysine (Sigma)-coated cell culture flasks.
After 10 days, the loosely attached oligodendrocyte progenitor cells
were separated from the glial feeder layer by 16 h of mechanical
shaking at 210 rpm, 37C. The collected oligodendrocyte progenitor
cells were further cultured either in Sato medium as described previ-
ously (Moransard et al., 2010) or in Dulbecco’s modified Eagle’s
medium/F12 (Gibco), 10 mM N-acetyl-L-alanyl-L-glutamine (L-GLU)
(Biochrom AG), 1% Penicillin-Streptomycin (Gibco), 2% B-27 supple-
ment (Gibco) on poly-D-lysine coated cell culture flasks.
Bone marrow-derived macrophages were prepared from bone
marrow cells isolated from the femur and tibia. Bones were flushed
with Hanks’ balanced salt solution and the cell suspension was forced
through a 70-mm mesh. Collected cells were resuspended in complete
macrophage medium containing Dulbecco’s modified Eagle’s medium,
30% L929 cell-conditioned medium (source of macrophage colony-
stimulating factor), 20% horse serum, 10 mM HEPES (Gibco) and
10 mM L-GLU and cultured at 37C, 5% CO2. After 7 days, virtually
100% of the cells expressed the macrophage markers CD11b and
F4/80. The cells were harvested by scraping on ice and frozen in
90% foetal calf serum and 10% dimethyl sulphoxide at a density of
5–10  106 cells/ml. Thawed cells were cultured in either Dulbecco’s
modified Eagle’s medium containing 10% foetal calf serum (PAA
Laboratories GmbH), 2 mM L-GLU and 20mg/ml gentamicin (Sigma)
or the same medium without serum.
BV2 cells (lab stock) were cultured in Dulbecco’s modified Eagle’s
medium containing 10% foetal calf serum, 2 mM L-GLU and 20 mg/ml
gentamicin.
OLIneu cells (kindly provided by Dr J. Trotter) were cultured as
described for primary oligodendrocyte progenitor cells.
To determine NG2 expression, all cell types were seeded on 3 cm
culture dishes at 1.0–2.0  106 cells/dish and treated with cytokines
for 48 h prior to real-time polymerase chain reaction or western
blot analysis. For immunocytochemistry, cells were grown at similar
densities on glass cover slips.
Isolation of central nervous system
mononuclear cells
CNS-mononuclear cells were isolated as described previously
(Moransard et al., 2010). Briefly, brains and spinal cords of animals
perfused with Hank’s balanced salt solution were minced with a scalpel
blade and digested for 30 min at 37C in Hank’s balanced salt solution
containing 50mg/ml DNase I and 100mg/ml collagenase/dispase
(Roche). The digestion was quenched on ice and passed through a
100mm nylon mesh (BD Biosciences) and centrifuged, after which the
pellet was resuspended in 30% Percoll (Sigma). The gradient was
centrifuged at 29 000 g for 30 min at 4C (Kontron Instruments).
The top layer containing myelin was removed by aspiration, and the
interphase containing mononuclear cells was collected, diluted 3-fold
with Hank’s balanced salt solution and collected by centrifugation
at 300 g.
Flow cytometric analysis
Cells were resuspended in flowcytometry buffer containing 2% foetal
calf serum, 5 mM ethylenediaminetetraacetic acid, 0.01% NaN3 in
phosphate buffered saline. Prior to staining with the appropriate anti-
bodies, Fc receptors were blocked by incubation with anti-mouse
CD16/32 (Fc-block, BD PharMingen). 7-amino-actinomycin D
(7-AAD) was used to exclude non-viable cells. All flow cytometric
data was obtained with a CyFlow flowcytometer (Partec). Data ana-
lysis was performed with FlowJo.
Infiltrating mononuclear cells were distinguished from CNS-resident
microglia (CD45int/CD11b + /F4/80 + ) on the basis of their high CD45
expression. Within this population the following cell types were distin-
guished using gating as indicated between brackets: CD4 T cells
(CD3 + /CD4 + ), CD8 T cells (CD3 + /CD8 + ), Granulocytes (CD11b + /
Gr1 + ), lyDCs (lymphoid dendritic cells; CD11c + /CD11b-/F4/80-),
myDCs (myeloid DCs; CD11c + /CD11b + /F4/80), inflDCs (inflamma-
tory DCs; CD11c + /CD11b + /F4/80 + ), pDCs (plasmacytoid DCs;
CD11c + /B220 + /Gr1 + ), B cells (CD11c/B220 + /Gr1),
Macrophages (CD11c/CD11b + /F4/80 + ).
Western blotting
To determine the amount of cell-bound NG2, cultured cells were
scraped on ice in lysis buffer containing 1% Nonidet P40 (Igepal CA
630, Fluka), 50 mM Tris, 150 mM NaCl, 5 mM ethylenediaminetetraa-
cetic acid and a cocktail of protease inhibitors (Complete Mini, Roche),
after which the lysates were cleared from insoluble material by centri-
fugation. To determine the amount of secreted NG2, cell-conditioned
media were collected and concentrated 10-fold using Amicon Ultra
centrifugal filter devices with a cut-off of 100 kDa (Amicon). Both
lysates and cell conditioned-media were incubated for 3 h at 37C
with Chondroitinase ABC (Sigma) in order to remove the chondroitin
side chain of NG2 prior to incubation with an appropriate volume of
Laemmli buffer at 80C.
The protocol to isolate soluble and detergent-extractable NG2 frac-
tions from CNS tissue is based upon the methods published by Asher
et al. (2005). In brief, spinal cords isolated from EAE diseased mice
were homogenized on ice with a douncer in the same buffer as used
for cultured cells but omitting NP-40. The resulting lysate was cleared
of insoluble material by low-speed centrifugation (3000 g, 10 min). The
supernatant contains soluble NG2, whereas detergent-extractable NG2
was recovered by resuspending the pellet in lysis buffer containing
1% NP-40. Finally both lysates were cleared from remaining insoluble
material by centrifugation (15 000 g, 10 min) followed by deter-
mination of the protein concentration using a BCA protein assay kit
(Pierce) and incubation with an appropriate volume of Laemmli buffer
at 80C.
For western blotting for NG2 equal amounts of protein were loaded
on NuPAGE 3–8% Tris-acetate gels (Invitrogen). Probing for b-tubulin
and/or b-actin was performed to control for loading. Images of west-
ern blots were obtained and quantified using the GE Healthcare
ImageQuant 350 system and accompanying software.
Immunohistochemistry and
immunocytochemistry
Mice were CO2 anaesthetized and perfused with 25 ml Ringer solution
(Braun Medical AG). Immunohistochemistry was performed on 10–
15 mm frozen, 4% paraformaldehyde- or methanol-fixed longitudinal
or cross sections of thoracic and lumbar spinal cord. Sections were
thawed, fixed and blocked (5% foetal calf serum, 0.01% Triton, phos-
phate buffered saline) prior to incubation with primary antibody 1/200
in blocking buffer for 24 h. After washes with phosphate buffered
saline, sections were incubated with the appropriate secondary anti-
body in block buffer for 2 h. After counterstaining with DAPI
(Molecular Probes) sections were mounted in Mowiol embedding me-
dium (Mowiol 4-88, Calbiochem) containing 0.1% 1,4-diazabicyclo-
[2.2.2]-octan (DABCO, Fluka). Immunocytochemistry on cultured cells
NG2 expression by macrophages in EAE Brain 2011: 134; 1315–1330 | 1317
was performed using the same protocol directly after a short wash and
fixation of the cells with 4% paraformaldehyde for 10 min. Images
were obtained on either a Zeiss Axiovert 40 or a Leica SP5 confocal
microscope.
Histology
Mice were sacrificed with CO2. Histology was performed as described
recently (Prinz et al., 2006). Spinal cords were removed and fixed in
4% buffered formalin and embedded in paraffin before staining with
haematoxylin and eosin or Luxol fast blue to assess the degree of
demyelination, MAC-3 (BD PharMingen) for macrophages and micro-
glia, CD3 for T cells (Serotec), B220 (BD PharMingen) for B cells, APP
for amyloid precursor protein (Chemicon) and glial fibrillary acidic pro-
tein for astrocytes (Dako).
Electron microscopy and evaluation of
remyelination
Electron microscopy and evaluation of remyelination was performed as
recently described (Raasch et al., 2011). Epon-embedded, glutaraldehyde-
fixed spinal cord slices from lumbar spinal cords (L1–L4) from five
wild-type and five NG2 animals at Day 40 post-immunization. Four
wild-type and three NG2 age- and sex-matched healthy control ani-
mals were prepared, cut and stained with toluidine blue. This staining
allowed clear distinction between normal and inflamed white matter
by light microscopy. The tissue was then trimmed and reoriented so
that ultrathin cross sections of the spinal cord could be cut and treated
with uranyl acetate and lead citrate. Thirty electron micrographs from
within spinal cord sections were obtained at 13 500 magnification
from each animal. Of these, 10 images for each animal were randomly
selected and axon diameter and myelin thickness were measured using
the analySIS Dock System (Soft Imaging System GmbH). Within each
image all axons with diameters of 4250 nm were evaluated, axons
with smaller diameters were omitted, since these are usually unmyeli-
nated axons. This meant that at least 130 axons per animal were
evaluated. G-ratios were defined as diameter of the axon divided by
fibre diameter (axon plus myelin). We calculated a G-ratio for each
fibre and subsequently averaged all G-ratios from one spinal cord. In
addition, the number of myelinated fibres in relation to all fibres was
expressed as percentage of myelinated axons to all visible axons.
Electron micrographs were obtained using a Philips CM 100 electron
microscope.
RNA isolation and real-time polymerase
chain reaction
Whole-cell RNA from cultured cells was extracted using the
NucleoSpin-RNA II kit (Macherey–Nagel). RNA from mouse tissues was
extracted by homogenization in TRIzol (Invitrogen) according to the
manufacturer’s instructions. RNA was reverse-transcribed using
random hexamers and AMV reverse transcriptase (Promega). The
complementary DNA equivalent to 50 ng of total RNA was amplified
by polymerase chain reaction in an ABI PRISM 7700 detection system
(PE-Applied Biosystems) using TaqMan Universal PCR Master Mix
(Applied Biosystems) and quantified using the 2CT method using
18 s ribosomal RNA as a housekeeping gene. Relative RNA levels are
expressed as fold change compared to control. Primers and probes for
Taqman analysis for IL-2, IL-6, IL-10, TNF-, IFN-, TGF-b and NG2
were purchased from Applied Biosystems.
Proliferation assay
OLIneu were seeded in a 96-well plate and treated with cytokines for
16 h before the addition of 5 mCi/ml 3H-thymidine (GE Healthcare).
After incubation for 16 h at 37C the cells were harvested directly
onto a glass fibre filter membrane using a 96-well plate harvester.
The filters were dried at 60C, sealed in a plastic bag containing
scintillation fluid (PerkinElmer) and measured in a beta-counter
(PerkinElmer).
Statistical analysis
For data obtained in vivo we performed unpaired, two-tailed Student’s
t-tests assuming equal variances. For data obtained in vitro we per-
formed paired, two-tailed Student’s t-tests assuming equal variances.
Numbers following the  sign represent standard error (SEM).
Results
NG2 protein accumulates at sites of
infiltrating leucocytes in experimental
autoimmune encephalomyelitis
In the injured CNS, NG2 protein levels are often elevated at sites
of tissue damage and/or inflammation and increased NG2 levels
remain associated with the glial scar (Levine, 1994; Fawcett and
Asher, 1999; Morgenstern et al., 2002; Alonso, 2005; Tan et al.,
2005, 2006). However, in EAE and multiple sclerosis, changes in
NG2 levels have been less well described (Di Bello et al., 1999;
Reynolds et al., 2002). Examination of NG2 and cytokine messen-
ger RNA expression by quantitative real-time polymerase chain
reaction in the spinal cord at different EAE disease stages
showed that at peak disease on Day 18 post-immunization (aver-
age score 2.78  0.15) NG2 messenger RNA levels are signifi-
cantly elevated and remain elevated in the remission phase (Day
43 post-immunization, average score 2.13  0.07) (Fig. 1A).
Notably, the NG2 expression profile correlates well with the ex-
pression of TGF-b in the spinal cord, with high expression main-
tained in the remission phase (Fig. 1A). In contrast messenger
RNA expression levels of IL-2, IL-6, IL-10, TNF- and IFN-
subsided after the peak phase (Fig. 1A).
Since NG2 exists in both cell-bound and secreted forms
(Nishiyama et al., 1995; Stallcup, 2002; Asher et al., 2005), we
examined the expression of both soluble and detergent-extracted
NG2 protein in spinal cord at different EAE stages by western blot
(Fig. 1B). Both the 300 kDa cell-bound and 290 kDa secreted
forms of NG2 are significantly elevated during EAE. The highest
amount of detergent-extracted NG2 is detected at the peak phase
whereas soluble NG2 increased over the course of the disease
(Fig. 1B and C).
We investigated by immunohistochemistry if the increase in
NG2 protein was restricted to sites of leucocyte infiltration in the
spinal cord (Fig. 1D). In the spinal cord of healthy mice (naı¨ve),
NG2 is expressed by pericytes associated with blood vessels, men-
ingeal cells and oligodendrocyte progenitor cells (insert shows the
typical stellar appearance of oligodendrocyte progenitor cells).
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Figure 1 NG2 is upregulated and accumulated in and around areas of leucocyte infiltration at peak and remitting stages of EAE. (A)
Quantitative real-time polymerase chain reaction analysis of NG2 and cytokine messenger RNA expression in spinal cord at different EAE
stages. NG2 messenger RNA expression is significantly increased at peak and remission (rem.). The expression of NG2 messenger RNA
correlates well with TGF-bmessenger RNA expression, but not with the expression of IL-2, IL-6, IL-10, TNF- or IFN-. (B and C) Western
blot and corresponding densitometric quantitation of soluble and detergent-extracted NG2 in spinal cord lysates from EAE diseased mice.
Both soluble and detergent-extracted NG2 protein amounts are significantly elevated in spinal cord at peak and remission. (D)
Immunohistochemistry for NG2 in longitudinal sections of spinal cord. In the spinal cord of naı¨ve animals NG2 expression is confined to
blood vessels and oligodendrocyte progenitor cells. Insert shows an electronically 3 magnified image of a stellate oligodendrocyte
progenitor cell in the boxed area. NG2 expression typical for the meninges (arrow) and satellite cells of the dorsal root ganglia (arrow
head) are illustrated in the remission panel. At peak and remission, NG2 immunoreactivity is increased in and around areas of infiltrating
leucocytes, identified by DAPI staining as clustered nuclei. NG2 immunoreactivity is diffuse and does not resemble the classic oligo-
dendrocyte progenitor cell morphology. Inserts show electronically 3-magnified images of the boxed areas. In normal appearing spinal
cord at remission (rem. n.a. Sp.C.), NG2 immunoreactivity is not increased and is localized to oligodendrocyte progenitor cells and blood
vessels. Bars represent mean  SEM; n = 4; *P50.05; **P50.01 versus naı¨ve wild-type control.
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NG2 expression typical for the meninges (arrow) and satellite cells
of the dorsal root ganglia (arrow head) are illustrated in the re-
mission panel. At peak disease, NG2-immunoreactivity is clearly
elevated within and around the borders of the area occupied
by infiltrating leucocytes (outlined area). Importantly, within
and in close proximity of these sites of leucocyte infiltration,
Olig2 + oligodendrocyte progenitor cells are abundantly present
(Supplementary Fig. 3). Note that within infiltrates some areas
are completely devoid of NG2-immunoreactivity, probably a sign
of extensive tissue damage. The insert illustrates that NG2 is no
longer restricted to stellar oligodendrocyte progenitor cells but
now has a rather diffuse distribution, which is maintained at
the remission stage of EAE. In contrast, in the normal appearing
spinal cord at remission, distribution of NG2 is indistinguishable
from its distribution in healthy mice. Thus both cell-bound and
secreted NG2 are upregulated in the spinal cord during EAE and
accumulate at sites of leucocyte infiltration.
TGF-b increases NG2 expression and
secretion by macrophages and
oligodendrocyte progenitor cells
During EAE the CNS is subjected to a steep increase in the con-
centration of disease-mediating cytokines (Fig. 1A) that could po-
tentially trigger NG2 accumulation by increasing oligodendrocyte
progenitor cell numbers and/or NG2 expression by oligodendro-
cyte progenitor cells. In addition to oligodendrocyte progenitor
cells, both macrophages and the CNS-resident microglia are
potential producers of NG2 (Bu et al., 2001; Jones et al., 2002;
Yokoyama et al., 2006; Fiedorowicz et al., 2008; Matsumoto
et al., 2008; Smirkin et al., 2009; Zhu et al., 2010).
We treated bone marrow-derived macrophages and the oligo-
dendrocyte progenitor cell line OLIneu with a variety of cytokines
with known roles in EAE, followed by quantitative real-time poly-
merase chain reaction analysis. Notably, only TGF-b increases
expression of NG2 messenger RNA in both OLIneu and macro-
phages (Fig. 2A). In addition IL-6 increased NG2 expression in
OLIneu to a similar extent. Subsequent 3H-thymidine incorpor-
ation assays indicated that the TGF-b-induced increase in NG2
messenger RNA in OLIneu is not due to enhanced proliferation
(Supplementary Fig. 1). To test if primary oligodendrocyte pro-
genitor cells are capable of secreting NG2 and if secreted and/or
cell-bound NG2 protein levels are altered by TGF-b, oligo-
dendrocyte progenitor cell-conditioned media and cell lysates
were analysed by western blotting (Fig. 2B). TGF-b treatment
of primary oligodendrocyte progenitor cells demonstrated that
both secreted and cell-bound NG2 amounts increase after 48 h.
A time course of TGF-b treatment of OLIneu confirmed these
results (Supplementary Fig. 2). Collectively these data show that
TGF-b treatment of oligodendrocyte progenitor cells induces an
increase in cell-bound and secreted NG2 without influencing cell
proliferation.
To investigate if macrophages and/or microglia express NG2
protein and possibly secrete NG2 in response to cytokines we
treated bone-marrow derived macrophages and the microglial
cell line BV2 (Bocchini et al., 1992) with IL-10, TNF-, IFN- or
TGF-b and analysed their conditioned media and cell lysates by
western blotting. Although untreated macrophages express a small
amount of NG2, TGF-b triggers a significant increase in both
cell-bound and secreted NG2 (Fig. 2C and D). In contrast, untreat-
ed microglia do not express NG2, and TGF-b induced expression
of a small amount of cell-bound, but not secreted, NG2 (Fig. 2E).
Notably, a comparative western blot showed that the amount of
cell-bound NG2 expressed by microglia is negligible and barely
visible compared to the amount produced by either macrophages
or oligodendrocyte progenitor cells, with the latter producing the
highest amount of cell-bound NG2 (Fig. 2F).
Subsequent immunocytochemical analysis (Fig. 2G) showed that
OLIneu cells are always NG2 + and TGF-b treatment elicits a
modest increase in NG2 immunoreactivity. Untreated macro-
phages are primarily NG2 although occasionally a NG2 + cell is
detected. TGF-b treatment triggers a substantial increase in the
number of NG2+ macrophages but the intensity of
NG2-immunoreactivity varies between cells. Notably, NG2 immu-
noreactivity was never observed in microglia after any of the treat-
ments. In summary, these data indicate that both macrophages
and oligodendrocyte progenitor cells upregulate NG2 expression
and secretion in response to TGF-b, whereas microglia only pro-
duce cell-bound NG2 at low levels in response to TGF-b and do
not secrete NG2.
NG2 is not required in experimental
autoimmune encephalomyelitis
The TGF-b-induced increase in NG2 expression in oligodendrocyte
progenitor cells and macrophages, which may underlie the accu-
mulation of NG2 at sites of leucocyte infiltration, is likely to be an
important response of the CNS to injury; however, its function is
currently unclear.
Therefore, we subjected NG2-deficient (NG2 knockout) mice
(Grako et al., 1999; de Castro et al., 2005; Kucharova and
Stallcup, 2010) and littermate control (wild-type) mice to EAE
and followed disease progression (Fig. 3A) and weight loss
(Fig. 3B). The absence of NG2 has no significant effect on EAE
onset, disease severity or the extent or rate of recovery.
To investigate if the lack of NG2 influences demyelination, neur-
onal damage and/or astrocyte activation, histology on thoracic
spinal cord cross-sections was performed (remission stage)
(Fig. 3C). Quantitation of Luxol fast blue staining revealed that
the extent of demyelination is similar in NG2 knockout and wild-
type mice (Fig. 3D). Also the number of APP + deposits, indicative
of damaged neurons, and glial fibrillary acidic protein + astrocytes
are comparable in wild-type and NG2 knockout animals.
The expression of NG2 by macrophages in vitro and the accu-
mulation of NG2 at sites of leucocyte infiltration suggested that
NG2 might modulate the inflammatory response in EAE. Therefore
different leucocyte subsets were monitored during the course of
EAE in the CNS, spleen and inguinal lymph nodes by histology and
flow cytometry but were not found to differ between NG2 knock-
out and wild-type mice (Fig. 3C–E; spleen and lymph node data
not shown). Specifically, histology showed that at remission
(Day 29) infiltrating T-cells (CD3), B-cells (B220) and macrophages
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Figure 2 TGF-b induces expression and secretion of NG2 by macrophages and oligodendrocyte progenitor cells in vitro. (A) Analysis of
NG2 messenger RNA expression in (primary bone marrow-derived) macrophages (Mac.) and OLIneu treated with different cytokines
(24 h) by quantitative real-time polymerase chain reaction. NG2 expression is significantly increased by treatment with TGF-b in OLIneu
and macrophages. IL-6 also increases NG2 expression in OLIneu. (B) Representative western blot for NG2 of primary oligodendrocyte
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(Mac-3) are present in comparable numbers in the CNS of
wild-type and NG2 knockout mice (Fig. 3C and D). In agreement,
flow cytometric analysis at remission did not reveal differences in
any of the leucocyte populations tested, including T cells, gran-
ulocytes, different dendritic cell types, microglia, and importantly,
blood-derived macrophages (Fig. 3E, CNS).
Since NG2 is prominently accumulated within and around areas
of leucocyte infiltration, we assessed whether the size and location
of the infiltrates within the thoracic and lumbar spinal cord (lumbar
not shown) are altered in NG2 knockout mice during the peak
phase by immunohistochemistry (Fig. 3F). Investigation of the dis-
tribution of macrophages/activated microglia (CD11b and F4/80)
indicates that cell number, total area covered by the cells and
penetration of the cells into the spinal cord in relation to the men-
inges are comparable in wild-type and NG2 knockout mice. Note
though the quite prominent overlap in macrophage distribution
(CD11b and F4/80) and NG2 immunoreactivity in wild-type mice.
Finally, because remyelination may be inhibited by NG2 accu-
mulation (Larsen et al., 2003) or delayed by NG2-deficiency
(Kucharova and Stallcup, 2010), we determined the extent and
quality of remyelination by electron microscopy at Day 40
post-immunization and in healthy control animals of each geno-
type (Fig. 4A–E). Quantitation of the percentage of myelinated
axons, axon diameter, myelin thickness and G-ratio indicates that
axon integrity and remyelination are comparable between healthy
wild-type and healthy NG2 knockout mice and at Day 40 post-
immunization between both genotypes. As expected though,
myelination is reduced in Day 40 post-immunization animals of
both genotypes compared to myelination in healthy controls.
The similar increase in the G-ratio at Day 40 post-immunization
strongly suggests that initial demyelination was extensive in the
experimental groups. The comparable G-ratios between wild-type
and NG2 knockout animals at Day 40 post-immunization, how-
ever, show that remyelination occurs with similar efficiency in both
genotypes. In summary, NG2 deficiency has no influence on EAE
disease outcome, the extent of CNS tissue damage, cellular inflam-
matory response, demyelination or remyelination.
Central nervous system resident cells
are responsible for NG2 accumulation
within and around infiltrates
Although our in vitro data indicates that both oligodendrocyte
progenitor cells and macrophages upregulate and secrete NG2 in
response to TGF-b, it still remains to be established if these cell
types actually contribute to NG2 accumulation at sites of leucocyte
infiltration in the CNS during EAE. Furthermore, it is possible that
NG2 expression by oligodendrocyte progenitor cells or macro-
phages may have different or even opposite functions in CNS
inflammation. To resolve these issues the following bone marrow
chimeras were created: wild-type mice containing NG2 knockout
bone marrow (knockout!wild-type) resulting in mice with NG2
deficiency only in the immune compartment, NG2 knockout mice
containing wild-type bone marrow (wild-type! knockout) creat-
ing mice that express NG2 only in bone marrow-derived leuco-
cytes, and wild type mice containing wild-type bone marrow
(wild-type!wild-type) as controls. We subjected these different
groups to EAE and, in good agreement with the previous results
(Fig. 3), weight-loss, onset, severity and progression of EAE were
all comparable in the different chimeras (Fig. 5A and B) indicating
that CNS- and leucocyte-derived NG2 do not have opposing or
compensatory roles.
To determine the relative contribution of CNS-resident and
CNS-infiltrating cells to the increase in NG2 in the spinal cord
during EAE, the expression of soluble and detergent-extracted
NG2 was examined by western blot (remission) (Fig. 5C and D).
Both 300-kDa cell-bound and 290-kDa shed NG2 are significantly
elevated in wild-type!wild-type and knockout!wild-type chi-
meras compared to NG2 levels in naı¨ve wild-type mice. Notably,
the amounts of soluble and cell-bound NG2 do not differ signifi-
cantly between these two chimeras. In sharp contrast, in spinal
cord lysates from wild-type! knockout chimeras cell-bound and
soluble NG2 were never detected by western blotting.
Analysis of thoracic spinal cord for NG2 and CD11b immunor-
eactivity by confocal microscopy showed that the location and
number of infiltrating CD11b + leucocytes do not vary significantly
between the different chimeras (Fig. 5D). However, the distribu-
tion of NG2 is strikingly different. Wild-type!wild-type chimeras
show NG2 accumulated within and around the area covered by
the infiltrating cells and co-localization of CD11b and NG2-
immunoreactivity can on occasion be observed (inserts).
Importantly, the distribution and accumulation of NG2 in the
knockout!wild-type chimeras is comparable and also in these
chimeras occasional CD11b and NG2 co-localization can be
seen, albeit significantly less frequently. In contrast, increased
NG2 expression and accumulation at sites of leucocyte infiltration
are clearly abolished in wild-type! knockout chimeras. Within the
infiltrate occasionally NG2-expressing cells (insert), which are also
Figure 2 Continued
progenitor cell lysates and culture medium after 48 h of TGF-b treatment. TGF-b upregulates both cell bound and secreted NG2. (C and D)
Western blot for NG2 of macrophage lysates and culture medium after cytokine treatment (24 h) and corresponding densitometric
quantitation. Untreated macrophages (Untr.) express and secrete a small amount of NG2. TGF-b elicited a significant increase in
cell-bound and secreted NG2. (E) Treatment of the microglia cell line BV2 with cytokines followed by western blot analysis of cell lysates
and culture media. Microglia express cell-bound NG2 only after TGF-b treatment. Secreted NG2 could not be detected. (F) Comparative
western blot of NG2 expression in macrophages, microglia (Micr.) and primary oligodendrocyte progenitor cells (OPCs). Macrophages
express a modest amount of NG2 although at lower levels than expressed by oligodendrocyte progenitor cells. NG2 expressed by
microglia is barely detectable. (G) Immunocytochemistry for NG2 in OLIneu, macrophages and microglia after cytokine treatment. TGF-b
treatment induces an increase in NG2 immunoreactivity in OLIneu. TGF-b elicits NG2 expression in most, but not all, macrophages
(co-stained with CD11b). NG2 immunoreactivity is never detected in microglia. Bars represent mean  SEM; n = 4; *P50.05;
**P50.01 versus control.
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Figure 3 NG2 deficiency does not alter EAE disease progression or inflammatory profile. (A) EAE progression monitored in mice
immunized with myelin oligodendrocyte glycoprotein using a method that scores the degree of paralysis on a scale of 1–5. Shown are the
combined results of two independent experiments with 24 NG2 deficient (NG2ko) and 36 wild-type (WT) animals in total. (B) Progression
of weight loss of the same mice. The fluctuations in weight correlate well with the degree of disability. NG2-deficiency has no effect on
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dimly CD11b + , can be observed. NG2-expressing cells were never
detected outside infiltrates in wild-type! knockout chimeras.
Notably though, the majority of CD11b + leucocytes do not ex-
press NG2. On average, 3–4 NG2+ cells are present within an
infiltrate, which are all faintly CD11b + .
Taken together, these results indicate that, although some
blood-borne NG2 + /CD11b + macrophages are present in the
CNS during EAE, CNS resident cells are responsible for the increase
in NG2 and its accumulation at sites of leucocyte infiltration.
Discussion
Oligodendrocyte progenitor cells are the
source of accumulated NG2 at sites of
leucocyte infiltration
The prominent increase in NG2 messenger RNA and protein in the
CNS during the course of EAE can in theory be derived from
various cellular sources. In particular oligodendrocyte progenitor
cells, CNS-infiltrating macrophages and CNS-resident microglia
are likely to express or upregulate NG2 during EAE. Indeed, our
in vitro data show that all three cell types are able to express or
upregulate NG2 expression in response to TGF-b but not in
response to various other cytokines that have been shown to
play a role in EAE. In addition, of the various cytokine expres-
sion profiles we tested, only expression of TGF-b correlated well
with the expression of NG2 over the course of EAE, suggesting
that TGF-b signalling may trigger increased NG2 expression in
EAE.
To determine which of the aforementioned cell types contribute
to NG2 accumulation in the CNS, we induced EAE in various NG2
knockout bone marrow chimeras. Our data show that large
amounts of NG2 are only accumulated in and around areas of
leucocyte infiltration if the recipient mice have a wild-type back-
ground (knockout!wild-type and wild-type!wild-type chi-
meras) showing that increases in NG2 are derived from a
CNS-resident cell type. Although it is possible that the lack of
NG2 on peripheral cells, in particular leucocytes, may hamper
CNS infiltration, which in turn could explain the lack of NG2 ac-
cumulation in the CNS, our immunohistochemical and flow cyto-
metric data (latter not shown for chimeras) showing a comparable
degree of cellular infiltration and lesion size argues against this
possibility.
Notably, in wild-type! knockout chimeras, in which NG2 is
expressed by bone marrow-derived cells (leucocytes) and not by
CNS resident cells, only a small amount of NG2 is present in the
CNS at peak EAE. Notably, lesion size and leucocyte infiltration
into the CNS are comparable to control EAE-diseased mice. This
small amount of NG2 is expressed solely by not yet fully charac-
terized, but bone marrow-derived, CD11b + amoeboid-shaped
cells. The actual amount of NG2 expressed by these cells in
the spinal cord of wild-type! knockout chimeras was too low
to be detected by western blot. Thus, NG2 found in and around
lesion sites in the CNS during the course of EAE is derived from
CNS resident cells rather than from leucocytes infiltrating
from the periphery into the CNS, practically ruling out blood-
borne macrophages as a major source of NG2 in EAE. These
data agree with observations by Rhodes et al. (2006) showing
that NG2 increases before ED1 + macrophages infiltrate into
lipopolysaccharide-injected rat brains.
Arguably, microglia as one of the potential brain resident
sources of NG2, are unlikely to contribute to NG2 accumulation
during EAE because of two observations. Firstly, even in the pres-
ence of TGF-b, the amount of cell-bound NG2 expressed by
microglia in vitro is negligible, and secreted NG2 is not produced
at all by microglia, which is in good agreement with microarray
data from our lab indicating that NG2 is not expressed by TGF-
b-treated primary microglia (Paglinawan et al., 2003). Secondly, in
knockout!wild-type chimeric mice, in which NG2 is only
expressed by CNS resident cells and not by leucocytes, only spor-
adic co-localization between NG2 and the microglial/macrophage
marker CD11b is observed despite leucocyte infiltration into the
CNS and lesion sizes being indistinguishable from control EAE-
diseased mice. Although the latter observation suggests that
some microglia may express NG2 during EAE, the amount pro-
duced by these cells cannot account for the large NG2 deposits
observed in and around infiltrates.
Taken together, our data suggest that oligodendrocyte progeni-
tor cells responding to TGF-b are the source of accumulated
NG2 in areas of CNS injury because Olig2 + oligodendrocyte pro-
genitor cells are prominently present in and around infiltrates
(Supplementary Fig. 3) and, in vitro, oligodendrocyte progenitor
cells produce significantly larger amounts of both cell-bound and
soluble NG2 in response to TGF-b than macrophages and micro-
glia. Our data is in accord with the observation that a single
Figure 3 Continued
EAE progression. (C and D) Histology and corresponding quantitation of thoracic spinal cord cross sections from EAE diseased NG2
knockout and wild-type mice at the remission stage for myelin loss (LFB = Luxol fast blue), neuronal damage (APP = amyloid precursor
protein), astrocyte proliferation (GFAP = glial fibrillary acidic protein), and infiltration of macrophages (MAC-3) and T-cells (CD3). In
addition the number of infiltrating B cells was assessed (B220). No significant differences in the number of infiltrating cells or degree of
demyelination or neuronal damage were detected (n = 5). (E) Flow cytometric analysis of CNS-infiltrating leucocytes. No significant
differences were found in any of the leucocyte populations tested. For gating strategy and definition of leucocyte populations refer to the
‘Methods’ section. Bars represent mean  SEM; n = 4. (F) Immunohistochemistry for macrophages/microglia (CD11b and F4/80) on
thoracic spinal cord cross-sections (peak). In wild-type animals, NG2 accumulation appears associated with infiltrates of CD11b and F4/80
positive macrophages/microglia. The number of infiltrating cells and area occupied does not noticeably differ between wild-type and NG2
knockout animals (scale bar = 200mm). PI = post-immunization.
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Figure 4 Normal myelination and remyelination in the absence of NG2. (A) Spinal cord sections from wild-type and NG2 animals Day 40
post-immunization (p.i.) and from sex- and age-matched healthy controls. (Top) Toluidine blue stained sections (scale bars = 500 mm), box
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injection of TGF-b into the rat basal ganglia elicits oligodendrocyte
progenitor cell activation and increased NG2 immunoreactivity
(Rhodes et al., 2006). Functionally, TGF-b may induce a reactive
phenotype in oligodendrocyte progenitor cells with a concomitant
increase in NG2 expression, which may precede differentiation
into oligodendrocytes and subsequent remyelination (McKinnon
et al., 1993).
Notably, the localization of accumulated NG2 at sites of leuco-
cyte infiltration appears rather diffuse and has a lack of distinct
cellular structure indicating that NG2 is partly secreted and incor-
porated into the extracellular matrix, which is confirmed by our
western blot data showing significant increases in both
saline-soluble and detergent-extracted NG2. Interestingly, the
shedding of NG2 appears to be a common response in CNS
injury because increases in both secreted and cell-bound NG2
have also been described in knife lesions of rat cerebral cortex
(Asher et al., 2005). Although the functional significance of se-
creted NG2 is currently unclear, the ability of the shed domain to
bind various growth factors and extracellular matrix components
suggests that it may function as a molecular ‘sink’, sequestering
growth factors and thereby limiting cell migration and/or prolifer-
ation. However, our data clearly show that NG2 does not limit
leucocyte proliferation and migration within the CNS or impair
clinical recovery in EAE. Notably, the latter observation, the pres-
ence of Olig2 + oligodendrocyte progenitor cells in and around
areas of leucocyte infiltration (Supplementary Fig. 3), and the
comparable extent of remyelination between NG2 knockout and
wild-type mice at the late remission phase also imply that oligo-
dendrocyte progenitor cell migration, proliferation and differenti-
ation are not majorly hampered by either NG2 accumulation or by
NG2 deficiency.
Unfortunately, the diffuse appearance of the NG2 staining in
infiltrates also makes it impossible to determine the number of
NG2 + oligodendrocyte progenitor cells and NG2 +/CD11b +
macrophages within these infiltrates by immunohistochemistry.
Additional attempts to quantify these cell populations by flow
cytometric analysis were also unsuccessful due to the lack of
anti-NG2 antibodies that work in flowcytometry.
NG2+ macrophages in experimental
autoimmune encephalomyelitis
Many recent reports have suggested that macrophage- and/or
microglia-like NG2 + cells accumulate in the CNS after a variety
of insults (Bu et al., 2001; Jones et al., 2002; Hampton et al.,
2004; Rezajooi et al., 2004; Yokoyama et al., 2006; Fiedorowicz
et al., 2008; Matsumoto et al., 2008; Smirkin et al., 2009; Gao
et al., 2010; Wu et al., 2010; Zhu et al., 2010). Despite this large
body of data, claims made in earlier studies indicating that NG2 +
cells are quite distinct from macrophages and microglia still cast
some doubts on the existence of NG2 + macrophages (Levine,
1994; Nishiyama et al., 1997; Di Bello et al., 1999; Dawson
et al., 2000). Some of these original studies have argued that
the occasional NG2 + microglia/macrophage engulfed or phagocy-
tozed rather than synthesized NG2 (Levine, 1994; Nishiyama
et al., 1997). Our data show that the existence of a
macrophage-like NG2+ cell in the CNS after insult can no
longer be logically disputed. NG2 + /CD11b + cells are clearly pre-
sent in leucocyte infiltrates in the spinal cord of EAE diseased
chimeras in which the CNS is NG2 deficient (wild-type! knock-
out chimeras). Furthermore, our in vitro data demonstrate that
NG2 expression can be induced in bone marrow-derived macro-
phages [CD11b + and F4/80 + expression of these cells shown in
(Moransard et al., 2010)]. Concurrent with our data is the obser-
vation of NG2 +/F4/80 + macrophages outside the CNS (Tigges
et al., 2008). The quantitative appreciation of the NG2 expres-
sion by macrophages in EAE lesions is difficult due to the fact
that the usually strongly CD11b + cuffs of the macrophages
are ‘flooded’ by soluble NG2. Interestingly, our observations in
the NG2 chimeras show that NG2+ /CD11b + cells constitute a
remarkably small part of all the CD11b + cells present in infil-
trates in the CNS indicating that these cells form a distinct sub-
population. This small number of NG2 +/CD11b + cells probably
explains why these cells have evaded conclusive identification for
so long.
Notably, the studies mentioned above have used slightly differ-
ent panels of antibodies and as a consequence it is not clear if we
have identified the same cell population or if there are different
subpopulations of NG2 + macrophage-like cells. The NG2+ cells
we observe in the wild-type! knockout chimeras are faintly
CD11b + and a proportion of these cells also express the dendritic
cell marker CD11c (data not shown), which would correspond well
with the NG2 + /OX42+ cells identified by a number of groups (Bu
et al., 2001; Hampton et al., 2004; Fiedorowicz et al., 2008; Gao
et al., 2010; Wu et al., 2010; Zhu et al., 2010), which may be
myeloid or inflammatory dendritic cells (Mildner et al., 2009;
Hesske et al., 2010).
NG2 plays no role in experimental
autoimmune encephalomyelitis
Despite the fact that a number of reports have identified immune
cells that express NG2 (Bu et al., 2001; Jones et al., 2002;
Hampton et al., 2004; Rezajooi et al., 2004; Yokoyama et al.,
2006; Fiedorowicz et al., 2008; Matsumoto et al., 2008; Smirkin
et al., 2009; Gao et al., 2010; Wu et al., 2010; Zhu et al., 2010)
Figure 4 Continued
depicts areas evaluated for myelination. (Centre) magnified sections from first row (scale bars = 100 mm). (Bottom) Electron micrographs
of evaluated regions (scale bars = 1 mm). (B–E) Percentage of myelinated axons compared to all visible axons (B), average axon diameter
(C), average myelin thickness (D) and average G-Ratio (E) show no significant differences between wild-type and NG2 animals in either
the Day 40 post-immunization or the control groups (P 4 0.1). Animals at Day 40 post-immunization show significantly reduced mye-
lination compared to healthy control animals (*P50.05; **P50.01). In all the graphs, each data point represents an individual animal.
Mean values are also depicted.
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Figure 5 CNS resident cells are responsible for increased NG2 expression and accumulation in and around areas of leucocyte infiltration.
(A and B) EAE progression and weight loss of the different chimeras. Wild-type!wild-type n = 10, knockout!wild-type n = 8,
wild-type! knockout n = 8. The fluctuations in weight correlate well with the degree of disability. EAE progression is comparable in all
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and increases in NG2 appear to be a pronounced injury response
both in the CNS and PNS (Levine, 1994; Nishiyama et al., 1997;
Di Bello et al., 1999; Moon and Fawcett, 2001; Jones et al., 2002;
Morgenstern et al., 2002; Reynolds et al., 2002; Tang et al.,
2003; Rezajooi et al., 2004; Asher et al., 2005; Tan et al.,
2005; Hossain-Ibrahim et al., 2007), in depth studies investigating
the role of NG2 in the immune response have been lacking. Only
two recent studies have tried to address the role of NG2+ macro-
phage/microglia-like cells in CNS inflammation directly. Data by
Gao et al. (2010) indicate that NG2 mediates the induction of
iNOS and inflammatory cytokine but not chemokine expression
in lipopolysaccharide-activated microglia. A report by Smirkin
et al. (2009) identifies several neuroprotective factors expressed
by Iba1 +/NG2 + macrophage-like cells and suggests that these
cells may ameliorate ischaemic brain damage. However, our data
demonstrate that NG2 deficiency has no significant effect on EAE
progression, leucocytes extravasation or migration within the CNS,
demyelination or the extent of neuronal damage, indicating that
NG2 does not play an important role in macrophage/microglia
function in autoimmunity.
In addition, NG2 accumulation has no effect on remyelination.
Although we did not address axon outgrowth directly, the com-
parably clinical recovery and extent of neuronal damage and de-
and remyelination at remission in NG2 knockout mice and
wild-type littermates indicate that NG2 is not a major inhibitory
or stimulatory factor in axon outgrowth, which is in good agree-
ment with the lack of improvement in axon outgrowth observed
in the NG2 knockout mouse after spinal cord injury (de Castro
et al., 2005; Hossain-Ibrahim et al., 2007).
In summary, the TGF-b-induced expression of NG2 in macro-
phages in vitro and expression of NG2 by a small population of
blood-borne macrophages in the CNS of EAE diseased mice are
indicative of a novel, potentially anti-inflammatory, macrophage
subpopulation. However, neither CNS-derived nor peripheral
macrophage expressed NG2 plays a role in the course of CNS
autoimmunity. Finally, although we have established here that
secreted and accumulated NG2 is derived from CNS resident
oligodendrocyte progenitor cells, the biological role of this rather
prominent response of the CNS to injury remains an open
question.
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